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Abstract 
Background: Pregnancy is considered a stressful event, results in higher levels of oxidative stress and considerable 
changes in physiological and metabolic functions such as gestational diabetes mellitus (GDM). Due to the cumu-
lative effect of antioxidants and considering the controversies in this area, this study was undertaken to investigate 
the total antioxidant capacity (TAC) of saliva in pregnant women whit gestational diabetes in comparison to non-
diabetic pregnant women.
Material and Methods: In this cross-sectional study (2015-16), a total of 31 women with a diagnosis of GDM and 
59 non-diabetic pregnant women were included in the diabetic and control groups, respectively. Salivary samples 
were collected by spitting method. When all samples were collected, total antioxidant capacity (TAC) was measu-
red with the use of a commercial kit following the manufacturer’s instructions. Data were analyzed with descriptive 
statistics and Mann-Whitney test using SPSS 18.
Results: Average TAC level in the saliva of women with gestational diabetes was 0.10 ± 0.14, with 0.04 ± 0.11 
in non-diabetic pregnant women. Nonparametric Mann-Whitney test showed that this difference was statistically 
significant (P=0.024).
Discussion: Under the limitations of the present study it can be concluded that there is an increase in oxidative stres-
ses during pregnancy, followed by an increase in the total levels of salivary antioxidants to counteract such stresses. 
Therefore, it is expected that determining the salivary antioxidant levels during pregnancy can be an alternative 
technique for the early diagnosis of diabetes.
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Introduction
Gestational diabetes mellitus (GDM) is abnormal gluco-
se metabolism during pregnancy (1,2), with a prevalence 
rate of 1.7-11.6%(3). GDM patients might be affected 
by pregnancy induced hypertension, polyhydramnios, 
infections, ketoacidosis and other conditions. Long-term 
poor control of blood glucose levels might give rise to 
chronic fetal hypoxia, disturbances in fetal growth, mal-
formations, neonatal hyperbilirubinemia, hypoglycemia, 
respiratory distress syndrome, etc (1,4,5).
The exact etiology of GDM is still to be elucidated. Cla-
rification of pathogenesis is important for early diagno-
sis and treatment, which improve the maternal and in-
fant prognoses. Recently, researchers have focused their 
attention on the relationship between oxidative stress 
and GDM (3,6,7).
Pregnancy is considered a stressful event, resulting in 
considerable changes in physiological and metabolic 
functions (6,8). In addition, pregnancy results in higher 
levels of oxidative stress due to high-energy demands 
and an increase in oxygen utilization. Oxidative stress 
is a consequence of an imbalance between production 
of free radicals and their scavenging by the antioxidant 
systems (6,9).
Antioxidants have the capacity to neutralize free radicals 
and reactive oxygen species, and interfere with oxidation 
of lipids, nucleic acids and proteins. They can function 
at four levels: A) They prevent free radical formation.
B) They prevent or inhibit the activity of free radicals 
after they are formed.
C) They repair damages inflicted by the activity of free 
radicals.
D) They increase the excretion or absorption of dama-
ged molecules (10).
There are two types of antioxidative agents in the body: 
[1] enzymatic, [2] non-enzymatic. The most important 
enzymatic antioxidants are superoxide dismutase (SOD), 
catalase and glutathione peroxidase (GPO) (11).
Due to the cumulative effect of antioxidants, it is advisa-
ble to measure the combined activity of all the antioxi-
dants or the total antioxidant capacity (TAC) instead of 
measuring the activity of each agent separately (12,13). 
Total antioxidant capacity (TAC) has been defined as the 
moles of oxidants that are neutralized by one liter of so-
lution; it is a biomarker used to measure the antioxidant 
potential of body fluids (14).
It has been reported that peroxidase activity, free-radical 
production and antioxidant defenses are disturbed in dia-
betes and pregnancy. Studies have shown that patients 
with type II diabetes mellitus exhibit severe oxidative 
stress (15), some studies demonstration enhanced oxi-
dation products and lowered antioxidant capacity in 
patients suffering from GDM, indicating that oxidative 
stress contributes to the initiation and progression of 
GDM (15-19). In contrast, a different study showed that 
pregnant women with diabetes had higher salivary levels 
of TAC (20).
Saliva consists of water and organic and inorganic com-
ponents, in addition to buffers, enzymes, growth factors, 
cytokines, immunoglobulins, mucins and other glyco-
proteins, as well as numerous defense systems such as 
the antioxidant defense system that are the first line of 
defense against oxidative stress (21,22).
Salivary components not only have a role in protecting 
oral tissues, but also they may reveal some systemic di-
seases. Therefore, salivary biomarkers might be used as 
tools for evaluating public health and for early diagnosis 
of some medical conditions (21,22). Saliva has several 
advantages over serum as a clinical tool because it is 
easy to collect and store saliva and it can be collected in 
sufficient amount for laboratory analyses. In addition, 
saliva can be collected as using non-invasive sampling 
techniques, provokes less anxiety and discomfort in pa-
tients and can be used for long-term evaluation of one 
particular condition (21-23).
In addition, it is much safer for researchers to collect 
saliva compared to blood tests because the latter is as-
sociated with the risk of exposure to hepatitis viruses 
or HIV. Therefore, the diagnosis of diseases with the 
use of saliva is much safer and cheaper than other me-
thods (23,24). Pregnancy and diabetes increase free ra-
dical production and are associated with disturbances 
in antioxidant defenses. Considering the controversies 
in this area, especially with regard to the important role 
of antioxidants in the prevention and treatment of many 
medical conditions, this study was undertaken to inves-
tigate the total antioxidant capacity (TAC) of saliva in 
pregnant women whit gestational diabetes in compari-
son to non-diabetic pregnant women.
Material and Methods
In this cross-sectional study, the study population con-
sisted of patients referred to private clinics, the De-
partment Oral Medicine, Tabriz Faculty of Dentistry 
and Al-Zahra Hospital in Tabriz during 2015-16. Being 
diabetic or non-diabetic and having any systemic disea-
se and drug consumption in pregnant women was con-
firmed by an obstetrician using an approved checklist 
before sampling.
Screening for and diagnosis of GDM according to In-
ternational Association of the Diabetes and Pregnancy 
Study Groups consensus: A 75-g OGTT (Oral Glucose 
Tolerance Test), with fasting plasma glucose measure-
ment and at 1 and 2 hours, was carried out at 24-28 wee-
ks of gestation in women not previously diagnosed with 
diabetes. The OGTT was performed in the morning after 
overnight fasting for at least 8 hours. The diagnosis of 
GDM was made when any of the following plasma glu-
cose values were exceeded: Fasting: ≥92 mg/dL, 1-hour: 
≥180 mg/dL, 2-hour: ≥153 mg/d (25).
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A total of 31 women with a diagnosis of GDM and 59 
non-diabetic pregnant women were included in the dia-
betic and control groups, respectively. All the subjects 
were matched for age, body mass index (BMI) and preg-
nancy with the control group.
Inclusion and exclusion criteria: The inclusion criteria 
consisted of a age range of 20-40 years, pregnant women 
with gestational diabetes, who were under treatment for 
diabetes, lack of any systemic diseases in the last three 
months, no past history of diabetes, not using any other 
drug not related with diabetes, no history of smoking, 
not using drugs that impair the balance of antioxidant 
defense system and intake of prescribed or over-the-
counter antioxidants (such as vitamins and carotenes) in 
the past year. This information was obtained by studying 
medical records and performing clinical examinations.
Saliva collection method: Salivary samples were collec-
ted by spitting method, in which the patient was asked 
to collect her saliva in the mouth and then transfer it into 
a special sterile plastic Falcon tube. This was repeated 
every 60 seconds for 5-15 minutes. To collect unstimu-
lated samples, each subject was asked to avoid eating 
or drinking or any other oral stimulation for 90 minutes 
prior to collecting the salivary samples. Using this me-
thod, almost 5 mL of saliva was collected. Saliva was 
collected for all the subjects between 8 and 9 am (fas-
ting) to avoid diurnal changes. The collected salivary 
samples were immediately placed on ice and transported 
to the laboratory, followed by centrifugation at 800 g for 
10 minutes at 4°C to separate squamous cells and debris. 
The samples were frozen at -80°C until preparation of 
all the samples was completed (26). When all samples 
were collected, total antioxidant capacity (TAC) was as-
sayed.
Total antioxidant capacity (TAC) assay: Saliva TAC was 
measured with the use of a commercial kit following the 
manufacturer’s instructions (ZellBio GmbH, Germany) 
on the basis of the oxidation reduction colorimetric as-
say at a wavelength of 490 nm. TAC level was conside-
red as the amount of antioxidant in the sample that was 
comparable to ascorbic acid action as a gold standard. 
This method can determine TAC with 0.1 mM sensiti-
vity (100 µmol/L). The intra- and inter-assay variation 
coefficients have been reported to be less than 3.2% and 
3.4%, respectively.
Ethical considerations: The study protocol conformed 
to the principles of the Declaration of Helsinki and was 
approved by the Medical Ethics Review Board of Tabriz 
University of Medical Sciences. Written informed con-
sent was obtained from all the volunteers regarding con-
fidentiality and anonymity of data collected. In addition, 
the details and aims of the study were disclosed. Patients 
were free to leave the study whenever the wished to.
Statistical analysis: Data were analyzed with descripti-
ve statistics (means, standard deviations and frequency 
percentages) using SPSS 18. In order to compare the 
numeric values of the parameters, Mann-Whitney test 
was used because data were not distributed normally in 
the case and control groups. Kolmogorov-Smirnov test 
was used to show normal distribution of parameters. In 
this study statistical significance was set at P<0.05.
Results
Of 90 patients, 31 were women with gestational diabetes 
and 59 others were non-diabetic pregnant women. Ave-
rage TAC level in the saliva of women with gestational 
diabetes was 0.10 ± 0.14, with 0.04 ± 0.11 in non-diabetic 
pregnant women. According to the data, average level of 
salivary TAC was higher in women with gestational dia-
betes (Fig. 1). Comparison of salivary TAC levels in wo-
men with gestational diabetes and non-diabetic pregnant 
women with nonparametric Mann-Whitney test (with 
respect to non-normal data) showed that this difference 
was statistically significant (P=0.024).
Fig. 1: Comparison of total salivary antioxidant levels in pregnant 
women with and without diabetes.
Discussion
Gestational diabetes mellitus (GDM) is a common condi-
tion during pregnancy and is associated with some com-
plications for the mother and fetus. Studies have shown 
that in societies with a higher rate of diabetes type II, 
gestational diabetes is more common, too, but the risk 
and development of the condition is variable (27). This 
condition is one of the most common complications of 
pregnancy, with a prevalence rate of approximately 7% 
(more than 2000 people per year) of all pregnancies in 
America (28).
Pregnancy is generally stressful (6,8) and is accompa-
nied by a high-energy demand and an increase in oxygen 
consumption, which might give rise to increased oxida-
tive stresses. Oxidative stresses occur when there is an 
imbalance between free radical production and the radi-
cal scavenging capacity of the antioxidant system. There 
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is evidence that prooxidant, free radical production and 
antioxidant defenses are disturbed in diabetes and during 
pregnancy (6,9,29).
Recently, the saliva as an accessible clinical sample has 
been in the spotlight of the researchers’ attention due to 
it’s the possession of different enzymes and molecules 
and distinctive function for the diagnosis and treatment 
of various diseases and their complications (30,31).
The present study was undertaken to compare salivary 
TAC levels in women with GDM and pregnant women 
without diabetes and the results showed that salivary 
TAC levels were higher in pregnant women with diabe-
tes. In a similar study in 2011, Surdacka et al. (20) eva-
luated 63 pregnant women with diabetes during the first 
semester of pregnancy and reported increased salivary 
TAC levels in such patients, consistent with the results 
of the present study. However, in contrast to the present 
study, there was no control group in that study.
Searches in PubMed, Google Scholar and EBSCO data-
bases showed that the study above is the only study on 
the subject and other limited studies that are available 
have only evaluated salivary antioxidants separately and 
to date no study has compared salivary TAC in pregnant 
women with and without diabetes. However, it should 
be pointed out that evaluation of TAC is very important 
because salivary antioxidants have synergistic effects 
(12,13). In addition, the majority of studies have evalua-
ted serum levels of antioxidants and only a few studies 
are available on salivary antioxidant levels. In a study by 
Shimada et al. (32) in 2016, the salivary melatonin levels 
were lower in pregnant women with diabetes compared 
to pregnant women without diabetes. 
In a study by Grissa et al. (33) in 2007, total serum an-
tioxidant defense capacity in diabetic mothers was lower 
compared to control subjects. In contrast, in another stu-
dy in 2011 by Al-Shebly et al. (6) plasma levels of total 
antioxidants were significantly higher in diabetic women 
compared to the control group.
Such differences might be attributed to differences in 
sampling methods, differences in techniques used to 
examine the samples in the laboratory, differences in 
mean ages of the patients, differences in the time requi-
red to be affected by diabetes and differences in metabo-
lic controls in patients.
The availability of only a limited number of studies and 
their contradictory results in relation to salivary and 
serum levels of antioxidants in pregnant women makes 
it difficult to reach a definite conclusion. However, un-
der the limitations of the present study it might be con-
cluded that during pregnancy there is an increase in oxi-
dative stresses, resulting in an increase in total salivary 
antioxidant levels to counteract such stresses. Therefore, 
determining salivary antioxidative levels might be con-
sidered an alternative technique for the early diagnosis 
of diabetes. Therefore, it is suggested that longitudinal 
studies be carried out to evaluate variations in salivary 
levels of antioxidants in pregnant women from the early 
days of pregnancy until the last days of it in order to de-
termine its validity for early diagnosis of GDM. 
The limitations of the present study include impossibility 
of making the samples uniform in physiological, hormo-
nal, nutritional and environmental terms, oral cavity sta-
tus, status of disease control, medications and blood su-
gar levels. In addition, diabetes is a multifactorial disease 
and a variety of factors, including genetics, nutrition and 
environment, play a role in its etiology. In addition, the 
quantity and quality of salivary compositions might be in-
fluenced by genetics, amount and type of food, smoking, 
physical activity level, hormone structure, level of stress 
and the oral cavity conditions in relation to dental caries 
and periodontal diseases. Therefore, further studies are 
recommended with larger sample sizes and further consi-
deration of confounding factors to achieve diagnostic and 
therapeutic protocols for diabetic patients.
Under the limitations of the present study it can be con-
cluded that there is an increase in oxidative stresses du-
ring pregnancy, followed by an increase in the total le-
vels of salivary antioxidants to counteract such stresses. 
Therefore, it is expected that determining the salivary 
antioxidant levels during pregnancy can be an alternati-
ve technique for the early diagnosis of diabetes. 
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